ENTITY

Therapix Biosciences (TRPX US)

4

Analysis

Health Care • United States

Therapix Biosciences Ltd provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. Therapix Biosciences serves customers worldwide.

more

Refresh

Exchange Announcement • 19 Jan 2022 00:27

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 07 Jan 2022 00:02

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 07 Jan 2022 00:00

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 06 Jan 2022 17:09

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 05 Jan 2022 00:42

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0

x